Literature DB >> 25833063

Anti-inflammatory effect of white wine in CKD patients and healthy volunteers.

Massimiliano Migliori1, Vincenzo Panichi, Rafael de la Torre, Montserrat Fitó, Maribel Covas, Alberto Bertelli, Daniel Muñoz-Aguayo, Alessia Scatena, Sabrina Paoletti, Claudio Ronco.   

Abstract

BACKGROUND: Mediterranean-style diet has been considered for its important beneficial effects on the progression of CV disease. Wine is an important component of the Mediterranean diet, and moderate wine drinkers have lower mortality rates than nondrinkers and heavy drinkers in epidemiologic studies. The beneficial effects of red wine are thought to be dependent on the polyphenol compounds such as resveratrol that exhibit potent antioxidant activity. However, white wine, although lacking polyphenols, contains simple phenols, such as tyrosol (Tyr) and hydroxytyrosol (OH-Tyr), characteristic also of extra-virgin olive oil, which may share similar antioxidant and inflammatory properties. PATIENTS AND METHODS: The effect of white wine and extra-virgin olive oil on inflammatory markers was evaluated in 10 healthy volunteers and in 10 patients with CKD (chronic kidney disease) K-DOQI stage III-IV in a prospective, single blind, randomized, cross-over trial. After two weeks of wash-out from alcoholic beverages, subjects were randomized to a cross-over design A-B or B-A of a 2-week treatment with white wine (4 ml/kg body weight, 0.48 g/kg of alcohol 12%, corresponding to 2-3 glasses/daily) and extra-virgin olive oil (treatment A) or extra-virgin olive oil alone (treatment B). The two study periods were separated by a two-week wash-out period. At baseline and at the end of each treatment, plasma levels of inflammatory markers C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and interleukin-8 (IL-8) concentration were determined. Urinary levels of Tyr, OH-Tyr, and their metabolites were measured at the same time.
RESULTS: During combined consumption of white wine and extra-virgin olive oil (treatment A), plasma levels of CRP and IL-6 decreased from 4.1 ± 1.8 to 2.4 ± 1.9 mg/l (p < 0.05) and from 5.3 ± 3.2 to 3.4 ± 2.3 mg/l (p < 0.05) in CKD patients. CRP decreased from 2.6 ± 1.2 to 1.9 ± 0.9 mg/l (p < 0.05), and IL-6 decreased from 2.2 ± 1.8 to 1.7 ± 1.3 mg/l (p = ns) in healthy volunteers. No significant variation versus baseline was observed during treatment B. A significant increase in urinary Tyr and OH-Tyr was observed during treatment A (white wine and extra-virgin olive oil).
CONCLUSIONS: Plasma markers of chronic inflammation were significantly reduced in CKD patients during the combined consumption of white wine and olive oil, suggesting a possible anti-inflammatory effect of this nutritional intervention.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25833063     DOI: 10.1159/000371570

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  10 in total

1.  Impact of a Proprietary Standardized Olive Fruit Extract (SOFE) on Cardio-Ankle Vascular Index, Visual Analog Scale and C-Reactive Protein Assessments in Subjects with Arterial Stiffness Risk.

Authors:  Pilar Pais; Agustin Villar; Santiago Rull
Journal:  Drugs R D       Date:  2016-12

2.  Alcohol Consumption Can be a "Double-Edged Sword" for Chronic Kidney Disease Patients.

Authors:  Zhenliang Fan; Jie Yun; Shanshan Yu; Qiaorui Yang; Liqun Song
Journal:  Med Sci Monit       Date:  2019-09-20

3.  Energy-Adjusted Dietary Inflammatory Index Is Associated With 5-Year All Cause and Cardiovascular Mortality Among Chronic Kidney Disease Patients.

Authors:  Ying Huang; Lei Zhang; Mengru Zeng; Fuyou Liu; Lin Sun; Yu Liu; Li Xiao
Journal:  Front Nutr       Date:  2022-06-14

4.  An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients.

Authors:  Carmela Cosola; Maria Teresa Rocchetti; Ighli di Bari; Paola Maria Acquaviva; Valentina Maranzano; Simone Corciulo; Agostino Di Ciaula; Domenica Maria Di Palo; Flavia Maria La Forgia; Sergio Fontana; Maria De Angelis; Piero Portincasa; Loreto Gesualdo
Journal:  Toxins (Basel)       Date:  2021-05-05       Impact factor: 4.546

5.  Influence of Phenol-Enriched Olive Oils on Human Intestinal Immune Function.

Authors:  Sandra Martín-Peláez; Olga Castañer; Rosa Solà; María José Motilva; Margarida Castell; Francisco José Pérez-Cano; Montserrat Fitó
Journal:  Nutrients       Date:  2016-04-11       Impact factor: 5.717

Review 6.  Developing criteria for evaluation of geroprotectors as a key stage toward translation to the clinic.

Authors:  Alexey Moskalev; Elizaveta Chernyagina; Vasily Tsvetkov; Alexander Fedintsev; Mikhail Shaposhnikov; Vyacheslav Krut'ko; Alex Zhavoronkov; Brian K Kennedy
Journal:  Aging Cell       Date:  2016-03-11       Impact factor: 9.304

Review 7.  Molecular Properties of Red Wine Compounds and Cardiometabolic Benefits.

Authors:  Melissa M Markoski; Juliano Garavaglia; Aline Oliveira; Jessica Olivaes; Aline Marcadenti
Journal:  Nutr Metab Insights       Date:  2016-08-02

8.  Wine and Olive Oil Phenolic Compounds Interaction in Humans.

Authors:  Anna Boronat; Miriam Martínez-Huélamo; Ariadna Cobos; Rafael de la Torre
Journal:  Diseases       Date:  2018-09-01

9.  Dietary intakes of total polyphenol and its subclasses in association with the incidence of chronic kidney diseases: a prospective population-based cohort study.

Authors:  Parvin Mirmiran; Emad Yuzbashian; Pegah Rahbarinejad; Golaleh Asghari; Fereidoun Azizi
Journal:  BMC Nephrol       Date:  2021-03-10       Impact factor: 2.388

Review 10.  Nutrition in Chronic Kidney Disease-The Role of Proteins and Specific Diets.

Authors:  Mugurel Apetrii; Daniel Timofte; Luminita Voroneanu; Adrian Covic
Journal:  Nutrients       Date:  2021-03-16       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.